Krummeich, Jennifer; Engelhardt, Verena; Caliendo, Cosima et al.
Trajectory of neuroligin/neurexin dysregulation associates with the establishment of an ASD-like phenotype in a mouse model of tuberous sclerosisEUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 32. 2024 S. 1471-1472
Ruffini, Nicolas; Altahini, Saleh; Weissbach, Stephan et al.
ViNe-Seg: deep-learning-assisted segmentation of visible neurons and subsequent analysis embedded in a graphical user interfaceBIOINFORMATICS. Bd. 40. H. 4. 2024
Lacombe, Didier; Bloch-Zupan, Agnes; Bredrup, Cecilie et al.
Working towards the ERN ITHACA international consensus statement on the Diagnosis and Management in Rubinstein-Taybi SyndromeEUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 32. 2024 S. 740-742
Yao, Siyue; Zhou, Xi; Gu, Min et al.
<i>FGFR1</i> variants contributed to families with tooth agenesisHUMAN GENOMICS. Bd. 17. H. 1. 2023
Hassunah, Pia; Thoma, Katharina; Camacho-Ordonez, Nadezhda et al.
Assessment of disease activity and management of patients with NFkB1 insufficiencyCLINICAL IMMUNOLOGY. Bd. 250. 2023 S. 34-34
Abdel-Salam, Ghada M. H.; Hellmuth, Susanne; Gradhand, Elise et al.
Biallelic<i> MAD2L1BP</i> (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumorsJCI INSIGHT. Bd. 8. H. 22. 2023
Nuzhat, Nafisa; Van Schil, Kristof; Liakopoulos, Sandra et al.
CEP162 deficiency causes human retinal degeneration and reveals a dual role in ciliogenesis and neurogenesisJOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 8. 2023
Holthoefer, Laura; Selig, Mareike; Engelhardt, Verena et al.
Deciphering MALSU1 in a consanguineous family with mitochondrial cardiomyopathyEUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 31. 2023 S. 156-156
Appiah, Bismark; Fullio, Camila L.; Ossola, Chiara et al.
DOT1L activity affects neural stem cell division mode and reduces differentiation and ASNS expressionEMBO REPORTS. Bd. 24. H. 8. 2023
Hebestreit, Helge; Lapstich, Anne-Marie; Brandstetter, Lilly et al.
Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort designECLINICALMEDICINE. Bd. 65. 2023